Renal Lymphoma: Treatment and Prognosis

This entry looks renal lymphoma, also known as primary renal lymphoma (PRL), one of the subtypes of lymphoma. 'Lymphoma' is an umbrella term that loosely refers to several dozen independent categorical types and subtypes of cancers of the lymphatic system.

 

What is Renal Lymphoma?

Renal lymphoma is defined as:

a non-Hodgkin's lymphoma arising primarily in the functional areas of the kidney (renal parenchyma), not resulting from invasion of an adjacent node or lymphomatous mass.

It is usually a B-cell lymphoma. If the lymphoma were a result of invasion from the adjacent nodes, we would call it lymphoma with renal involvement, or secondary renal lymphoma. But when it is clear that the lymphoma is originating as a kidney tumor, then it is called primary renal lymphoma (PRL).

It is much more common for kidneys to be an involved extra-nodal organ site in other lymphomas; perhaps just 3 to 8 percent of the time that the kidney is involved in lymphomas, it is a PRL.

In lymphoma circles, PRL is considered a controversial disease, meaning that not everyone agrees that it exists, since the kidneys are not lymphoid organs. In most cases, renal cell carcinoma is much more likely. Nonetheless, cases of PRL continue to be reported, although the disease is extremely, extremely rare.

What are the Symptoms of Renal Lymphoma?

Signs and symptoms of PRL are generally non-specific, meaning they could indicate many things, not just PRL. A person could experience flank pain or kidney pain as well as poor kidney functioning. Additionally, it's possible for a person with PRL to experience so-called B symptoms, such as unexplained weight loss, fatigue, and drenching night sweats, to name just a couple.

Treatment and Prognosis for Renal Lymphoma

PRL has been documented as a very aggressive disease, and in many cases, the mean survival time from diagnosis comes out to around a year. In other words, in the rare instances when PRL is diagnosed, it requires immediate therapeutic intervention, which is generally CHOP combination chemotherapy. The efficacy of Rituxan remains under investigation.

Sources

Photo: Pexels

More Articles

More Articles

There are two types of cancer: benign and malignant. Benign cancers are the kind that don't spread and don't threaten one's life. Malignant...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

The Follicular Lymphoma International Prognostic Index, or FLIPI, is a standardized guide to help oncological diagnosticians accurately calculate...

Diffuse large B cell lymphoma prognosis is contingent upon several factors, and can be determined by using a well-...

The term 'metastatic lymphoma' does not refer to a diagnosis. Unlike many of the subtypes of lymphoma we have...

Diagnosing lymphoma is one of the more difficult diagnoses to make in cancer medicine, and contrary to perception, diagnosing lymphoma is not made...

Burkitt's lymphoma is an aggressive B-cell lymphoma that is common in children...

Treatment for Non-Hodgkin’s Lymphomas (NHL) differs from patient to patient. The regimen used depends on the type of...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

Follicular lymphoma is classified as a Non-Hodgkin's Lymphoma. It is an indolent (slow-growing) cancer that affects...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

Lymphoma is not difficult to diagnose once a patient and doctor begin to look for signs of cancer. However, Lymphoma–especially...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

The lymphatic system, or lymph system, defends the body from foreign invasion by disease causing agents such as viruses, bacteria, or fungi. The...

Lymphoma is a cancer of the lymphatic system, causing B-cell or...